Clincosm LogoSign in Get a demo

Chronic Hepatitis C

Showing 51 - 75 of 351
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis C Trial in Beijing (interferon combined with ribavirin (PR) antiviral therapy, direct antiviral drugs (DAAs))

Unknown status
  • Chronic Hepatitis C
  • interferon combined with ribavirin (PR) antiviral therapy
  • direct antiviral drugs (DAAs)
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
Mar 6, 2020

Chronic Hepatitis C Trial in Worldwide (SOF/VEL)

Completed
Has Results
  • Chronic Hepatitis C
  • Adelaide, South Australia, Australia
  • +21 more
Feb 18, 2020

IFN-Induced Gene Expression in Obese and Non-Obese Chronic

Completed
  • Chronic Hepatitis C
  • Obesity
    • Palo Alto, California
      VA Palo Alto Health Care System
    Mar 2, 2020

    Chronic Hepatitis C, Hepatitis C, Hepatitis C, Chronic Trial in Antwerp, Chisinau (AT-527, Placebo Comparator)

    Completed
    • Chronic Hepatitis C
    • +2 more
    • Antwerp, Belgium
    • +1 more
    Feb 14, 2020

    'Fibrosis in Lost Hepatitis C Population - Track, Trace and

    Completed
    Has Results
    • Chronic Hepatitis c
      • Nijmegen, Gelderland, Netherlands
        Radboudumc
      Feb 4, 2020

      Chronic Hepatitis C Trial in Cairo (sofosbuvir plus daclatasvir, Sofosbuvir plus Ledipasvir)

      Unknown status
      • Chronic Hepatitis C
      • sofosbuvir plus daclatasvir
      • Sofosbuvir plus Ledipasvir
      • Cairo, Abbasseya, Egypt
        El Demerdash Hospital
      Dec 28, 2019

      Hepatitis C Elimination in the Netherlands

      Unknown status
      • Chronic Hepatitis c
        • Nijmegen, Gelderland, Netherlands
          Radboudumc
        Dec 18, 2019

        Hepatitis C Treatment and Atherosclerosis

        Completed
        • Chronic Hepatitis C
        • Atherosclerosis
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Dec 11, 2019

          Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A), Placebo to Grazoprevir 100 mg/Elbasvir 50 mg

          Completed
          Has Results
          • Chronic Hepatitis C
          • Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A)
          • Placebo to Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet
          • (no location specified)
          Nov 11, 2019

          Chronic Hepatitis C Trial (Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body

          Completed
          • Chronic Hepatitis C
          • Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body weight) PO Daily for up to 48 wks
          • (no location specified)
          Nov 21, 2019

          Chronic Hepatitis C, Hepatitis, Viral, Human Trial in London, Ottawa (EMZ702)

          Completed
          • Chronic Hepatitis C
          • Hepatitis, Viral, Human
          • London, Ontario, Canada
          • +1 more
          Oct 17, 2019

          Chronic Hepatitis C Trial in Rennes (AL-335, ACH-3102, Simeprevir)

          Completed
          • Chronic Hepatitis C
          • Rennes, France
            Biotrial
          Oct 15, 2019

          Chronic Hepatitis C Trial in Rennes, Tbilisi, Chisinau (AL-335 matching , AL-335)

          Completed
          • Chronic Hepatitis C
          • Rennes, Brittany, France
          • +2 more
          Oct 15, 2019

          Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and

          Completed
          Has Results
          • Chronic Hepatitis C
          • Be'er Sheva, HaDarom, Israel
          • +17 more
          Sep 18, 2019

          Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

          Completed
          Has Results
          • Chronic Hepatitis C
            • (no location specified)
            Sep 16, 2019

            Pulmonary Arterial Hypertension in Direct-Acting Antiviral

            Completed
            • Pulmonary Artery Hypertension
            • Chronic Hepatitis c
            • transthoracic doppler-echocardiography (TTE)
            • Olten, Switzerland
              Kantonsspital Olten
            Sep 19, 2019

            Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

            Completed
            Has Results
            • Chronic Hepatitis C
              • Bogotá, Colombia
              • +5 more
              Aug 12, 2019

              Chronic Hepatitis c Trial in Assiut, Assuit (Sofosbuvir , daclatasvir, Placebos)

              Unknown status
              • Chronic Hepatitis c
              • Sofosbuvir , daclatasvir
              • Placebos
              • Assiut, Assuit, Egypt
              • +1 more
              Sep 10, 2019

              Clinical Outcomes After Antiviral Therapy for Chronic Hepatitis

              Unknown status
              • Chronic Hepatitis C
              • Beijing, Beijing, China
                liver disease center, Beijing Ditan Hospital
              Aug 25, 2019

              "Real Life" Evaluation of Efficacy and Safety of Direct

              Unknown status
              • Chronic Hepatitis C
                • Cairo, Egypt
                • +2 more
                Jul 26, 2019

                Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Chronic

                Completed
                Has Results
                • Chronic Hepatitis C
                  • (no location specified)
                  May 23, 2019

                  Chronic Hepatitis C Trial in Worldwide (AL-335, Odalasvir (ODV), Simeprevir (SMV))

                  Completed
                  Has Results
                  • Chronic Hepatitis C
                  • Phoenix, Mauritius
                  • +10 more
                  Jun 24, 2019

                  Frequency of Anxiety and Depression in Chronic Hepatitis C

                  Unknown status
                  • Chronic Hepatitis c
                  • Direct Acting Antivirals
                  • (no location specified)
                  Jul 5, 2019

                  Chronic Hepatitis C Trial (Grazoprevir, Elbasvir, MK-5172A)

                  Completed
                  Has Results
                  • Chronic Hepatitis C
                  • (no location specified)
                  Jun 11, 2019

                  Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in

                  Completed
                  Has Results
                  • Chronic Hepatitis C
                    • Marseille CEDEX 08, Bouches-du-Rhone, France
                    • +69 more
                    Mar 13, 2019